CA2143863C - Hollow fiber membrane incorporating a polyimide and process for preparing same - Google Patents

Hollow fiber membrane incorporating a polyimide and process for preparing same

Info

Publication number
CA2143863C
CA2143863C CA002143863A CA2143863A CA2143863C CA 2143863 C CA2143863 C CA 2143863C CA 002143863 A CA002143863 A CA 002143863A CA 2143863 A CA2143863 A CA 2143863A CA 2143863 C CA2143863 C CA 2143863C
Authority
CA
Canada
Prior art keywords
polymer
hollow fiber
solution
solvent
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002143863A
Other languages
French (fr)
Other versions
CA2143863A1 (en
Inventor
Robert G. Andrus
Robert T. Ii Hall
Randal M. Wenthold
Louis C. Cosentino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minntech Corp
Original Assignee
Minntech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minntech Corp filed Critical Minntech Corp
Publication of CA2143863A1 publication Critical patent/CA2143863A1/en
Application granted granted Critical
Publication of CA2143863C publication Critical patent/CA2143863C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/02Inorganic material
    • B01D71/04Glass
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D67/00Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002Organic membrane manufacture
    • B01D67/0009Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0011Casting solutions therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/1672Apparatus for preparing dialysates using membrane filters, e.g. for sterilising the dialysate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/24Dialysis ; Membrane extraction
    • B01D61/30Accessories; Auxiliary operation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/02Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08Hollow fibre membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08Hollow fibre membranes
    • B01D69/085Details relating to the spinneret
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • B01D71/58Other polymers having nitrogen in the main chain, with or without oxygen or carbon only
    • B01D71/62Polycondensates having nitrogen-containing heterocyclic rings in the main chain
    • B01D71/64Polyimides; Polyamide-imides; Polyester-imides; Polyamide acids or similar polyimide precursors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • B01D71/66Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
    • B01D71/68Polysulfones; Polyethersulfones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001Combinations of extrusion moulding with other shaping operations
    • B29C48/0013Extrusion moulding in several steps, i.e. components merging outside the die
    • B29C48/0015Extrusion moulding in several steps, i.e. components merging outside the die producing hollow articles having components brought in contact outside the extrusion die
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/05Filamentary, e.g. strands
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • B29C48/10Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels flexible, e.g. blown foils
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/16Articles comprising two or more components, e.g. co-extruded layers
    • B29C48/18Articles comprising two or more components, e.g. co-extruded layers the components being layers
    • B29C48/21Articles comprising two or more components, e.g. co-extruded layers the components being layers the layers being joined at their surfaces
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/24Formation of filaments, threads, or the like with a hollow structure; Spinnerette packs therefor
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/74Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polycondensates of cyclic compounds, e.g. polyimides, polybenzimidazoles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2323/00Details relating to membrane preparation
    • B01D2323/12Specific ratios of components used
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2325/00Details relating to properties of membranes
    • B01D2325/02Details relating to pores or porosity of the membranes
    • B01D2325/022Asymmetric membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001Combinations of extrusion moulding with other shaping operations
    • B29C48/0012Combinations of extrusion moulding with other shaping operations combined with shaping by internal pressure generated in the material, e.g. foaming
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001Combinations of extrusion moulding with other shaping operations
    • B29C48/0018Combinations of extrusion moulding with other shaping operations combined with shaping by orienting, stretching or shrinking, e.g. film blowing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2039/00Use of polymers with unsaturated aliphatic radicals and with a nitrogen or a heterocyclic ring containing nitrogen in a side chain or derivatives thereof as moulding material
    • B29K2039/06Polymers of N-vinyl-pyrrolidones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2081/00Use of polymers having sulfur, with or without nitrogen, oxygen or carbon only, in the main chain, as moulding material
    • B29K2081/06PSU, i.e. polysulfones; PES, i.e. polyethersulfones or derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0058Liquid or visquous
    • B29K2105/0073Solution
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/04Condition, form or state of moulded material or of the material to be shaped cellular or porous
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2023/00Tubular articles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/731Filamentary material, i.e. comprised of a single element, e.g. filaments, strands, threads, fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/755Membranes, diaphragms

Abstract

The invention relates to asymmetric hollow fiber separative membranes based on polyimide polymer. The membranes are dry-wet spun into hollow fiber from a 15-25 % solution of a highly polar polyimide polymer using a precipitating solution in the lumen.

Description

;~ W094/07594 ' 2143:~B'63' PCI/US93/09639 HO~LOW ~IBER MEMBR~NE INCORPORATING A POLYIMIDE
AND PROCESS FOR PREPARING SAME
Backaround of the Invention 1. Field of the Invention.
This invention relates generally to improved asymmetrical, microporous,~hollow fibers incorporating a polyimide and to the process of hollow fiber production. In particular, the invention relates to asymmetrical, microporous, hollow fiber membranes with low water or blood leachable impurities. The process involves passing a polymeric solution through an outer annulus of die to create an annular stream and passing a precipitating fluid through the inner orifice of the die creating a stream within the annular stream resulting in hollow fiber formation.
2. DescriDtion of the Related Art.
Microporous, hollow fibers are polymeric capillary tubes having an outside diameters equal to about 1 mm or less and whose walls function as semipermeable membranes. The fibers are useful in separation processes involving transport mainly through sorption and diffusion. Such processes include dialysis, including hemodialysis, ultrafiltration, hemofiltration, blood separation, drug release in artificial organs and water filtration where ultra-pure water is needed such as in the electronic and pharmaceutical industries. Each of these applications has various requirements including pore size, strength, biocompatibility, cost and speed of production and reproducibility.
Given the varying uses to which this fiber may be applied, it is highly desirable that the hollow fiber membrane have as little leachable impurities as possible in water, blood, from 0% to saturated solutions of NaCl in water, and other similar type of aq~leous solutions. It is also typically desired that the membranes be easily or immediately wettable by water, blood and other types of aqueous solutions without the need for costly polymer additives, post fiber-formation treatments with wetting agents or both.
Related art hollow fibers for the aforementioned uses have typically included regenerated cellulose materials and modified polyacrylonitrile material. However, it is difficult to control the porosity and pore size of these fibers, and for some applications, composite membranes consisting of an ultra-thin layer contiguous with a more porous substrate are needed to provide the necessary mechanical strength.
Related art hollow fiber membranes have also been prepared from hydrophobic polymers such as polysulfones, aromatic polyamides and polyimides, and polyamide-imides.
However, the hydrophobic nature of these polymer presents difficulties with wetting these membranes when used in aqueous systems. Therefore, hydrophilic polymers such as polyvinyl alcohol, polyvinyl acetate co-polymers, polyvinylpyrrolidone and polyvinylpyrrolidine have typically been incorporated directly into the fibers to achieve a hydrophilic fiber that wets easily.
Alternatively, polyethylene glycol, glycerol and/or a variety of surfactants have been incorporated directly into the fibers or used post-fiber formation to achieve wettability.
For example, U.S. Patent No. 4,906,375 to Heilman, discloses a process comprising wet spinning a polymer solution made up of a solvent, about 12 to 20 wt.% of a first, y~ ; 2143863 hydrophobic polymer and 2-10 wt.% of a hydrophilic polyvinylpyrrolidclne polymer to achieve wettability. The two polymer solutions are simultaneously passing through a hollow internal core with a precipitant solution comprising an aprotic solvent in conjunction with at least 25 wt.% non-solvent.
However, the hollow fiber membranes so produced have limitations in hydrophilicity, water flux, etc. and by their very nature have limited useful applications.
U.S. Patent No. 4,432,875 to Wrasidlo et al., discloses reverse osmosis fiber membranes made from specific polyimide structures. saked onto the membrane is a polymeric, high molecular weight surfactant. The polymeric surfactant apparently takes the place of the hydrophilic polymer Heilmann reference and is used to increase the wettability of the resultant fiber membrane. The fiber produced using the Wrasidlo process, however, is limited to sheet membranes that have a ~ porosity significantly different than microporous hollow fiber membranes. Further, the ~baking on~ of the surfactant in Wrasidlo results in a fiber that is costly to manufacture, thus making the fiber's use economically impractical for smaller companies.
U.S. Pat. No. 3,719,640 to Le et al., discloses linear polymers of polyamide-imides having a specific formulation containing a cluaternizable nitrogen atom. When nitrogen is cluaternized, the polymer becomes hygroscopic and may be used as separatory membranes in such processes as desalination.
U.S. Pat. No. 4,900,449 to Kraus et al., discloses the use of polyimide polymers for pleated flat sheet type membranes.

W094/07594 2 ~ 4 3 8 6 3 PCT/US93/09639 The membranes and process described are limited in use to flat sheet membranes f~r water filtration applications. Such membranes have less than one-half the surface area available for filtration as the filter membranes of the present invention.
While the related art fibers discussed above are useful in many applications, there is and always has been a trade-off among properties including tensile strength, elasticity, porosity, flux, and sieving characteristics including molecular size cutoff, solute clearance, etc. Thus, new membranes are constantly needed which can offer advantages in particular applications with given property requirements.
None of the aforementioned references teach an asymmetric, microporous, hollow fiber membrane which is equally suitable in processes such as hemofiltration, plasma fitration, hemodialysis and water purification and which does not use some type of - polymer ~additive~ to render the resultant membrane hydrophilic.
A hollow fiber membrane that could be applied across a large range of applications would provide a decided advantage over related art fiber membranes. Additionally, a new and useful process is needed that will ensure that a uniformly porous, cost-performance effective hollow fiber is available to large and small companies alike. Specifically, a new and useful membrane and process is needed that is chemically inert to blood and water solutions, or both, within the normal blood pH range of 7.35-7.45 and also be rewettable after repeated sterilizations. It is also desirable that leachable additives such as surfactants and/or hydrophilic polymers are completely absent from the resultant fiber because residual toxic ~ 21~3863 substances are a major concern when hollow fiber membranes are used in medical applications or applications involving the semi-conductor industry. Such a hollow fiber membrane would provide a significant advantage over related art membranes.
Summary of the Invention It is an object of the hollow fiber membrane incorporating a polyimide and the process for preparing the same provided in accordance with the present invention to solve the problems outlined above that have heretofore inhibited the successful production of a cost-efficient, immediately wettable fiber without the use of PVP or surfactants, which maintains its rewettability after numerous steam and/or chemical sterilizations and which has a broad range of applications. The process of manufacturing a microporous hollow fiber membrane in accordance with the present invention enables the use of a unique hollow fiber membrane that, as will be shown, is chemically inert to aqueous solutions and/or blood, is rewettable after repeated steam and/or chemical sterilizations of at least 6-7 times, has superior clearance, sieving, and water permeability characteristics and is usable over a wide range of applications.
The hollow fiber membrane of the present invention includes about 15-25 wt.% of a fiber forming polymer selected from the group of polyimides and is characterized by the absence of polymer additives which increase wetability, wherein the hollow fiber membrane can be made so that is has a pore size range such that it rejects 100% of molecules (sieving coefficient of 0.0) having a molecular weight greater than about W094/07594 2 1 ~ 3 8 6 ~ PCT/US93/09639 65,000 daltons and rejects 0.0% of molecules (sieving coefficient of 1.~) having a molecular weight of about 6,000 daltons and less, and rejects from about 35% to 0.0% of molecules (sieving coefficient of 0.65 to 1.0) having a molecular weight of 17,000 daltons; and wherein at a blood flow rate of 300 mL/min and 1.35m2 of active surface area, the fiber has clearance rates of 225-270 for urea, 200-250 for creatinine, 170-225 for phosphate, and 125-150 for Vitamin B12 and wherein the fiber has high sieving coefficients of 0.0 for albumin, 0.65-1.0 for myoglobin, and 1.0 for inulin.
In addition, the invention includes a method of manufacturing the fibers. This process includes the steps of (a) dissolving the undegraded polyimide in the appropriate solvent system (b) forming an annular liquid by passing the polymeric solution comprising about 15-25 wt.% of a highly polar polyimide dissolved in an organic solvent and having a viscosity of about 1500-5000 cps through an outer annular orifice of a tube-in-orifice spinneret, (c) passing a precipitating solution comprising about 65-99 wt.% of an organic solvent and about 35-1 wt.% of water into the center of the annular liquid through the inner tube of the spinneret, (d) passing the polymer precipitate through the atmosphere or an augmented atmosphere, (e) quenching the polymer precipitate in a bath to form a hollow fiber; and (f) taking up the fiber at a rate of about 40-70 m/min.
The most significant advantage of the present invention is that the hollow fiber membranes so formed immediately wet with aqueous solutions without the use of PVP, glycerine, or other additives. This results in an economical fiber with a homogeneous sponge structure that requires no further mechanical, chemical or other treatment to establish aqueous solution wettability.
These and other objects and advantages of the present invention will become apparent during the course of the following detailed description and appended claims. The invention may best be understood with reference to the accompanying drawings, disclosure and examples wherein an illustrative embodiment is shown.

Brief Descri~tion of the Drawinas Figure 1 is a side elevational diagram with parts cut away depicting the process of the present invention;
Figure 2 is a side elevational detail view of the dry-jet wet spinning spinneret used in the process of the present invention;
Figure 3 is a fragmentary sectional detail view of the orifices of the spinneret;
Figure 4A is an enlarged, microscopic, cross-sectional view of the hollow fiber membrane in accordance with the present invention illustrating the ~homogeneous sponge-like~ structure;
Figure 4B is a greatly enlarged view thereof taken from the area enclosed by box 4B in Figure 4A;
Figure 5 is an enlarged detailed view of the hollow fiber membrane in accordance with the present invention illustrating the homogenous sponge-like structure taken at a 45~
angle of cross-section;

W094/07594 ~ 1 4 3 8 6 3 PCT/US93/09639 Figure 6A is an enlarged, microscopic cross-sectional view of prior art hollow fiber membranes illustrating Uvoidsn;
Figure 6B is a greatly enlarged detail view thereof taken from the area enclosed by box 6B in Figure 6A;
Figure 7 is an enlarged, microscopic cross-sectional view of hollow fiber membranes with voids.
Detailed Description of the Dr~w-n~s The process of the invention may be generally determined in view of Figures 1-3. A polymeric dope solution 12 comprising a polysulfone polymer and a polyvinyl pyrrolidone polymer dissolved in an aprotic solvent is prepared in a mixing vessel 14. The solution is then filtered in a filter press 16 and delivered by means of a pump 18 to a dry-jet wet spinning spinneret apparatus 20. This apparatus is discussed in further detail below.
Simultaneously, a diluent or precipitating solution 22 is prepared in a second mixing vessel 24 from water and a lower alcohol. This diluent solution is also delivered to the spinneret apparatus 20 by means of pump 26. The dope solution 12 and diluent solution 22 are spun from the spinneret apparatus 20 to form a hollow fiber 28. The hollow fiber 28 drops through a volume of gaseous fluid 30 which is enclosed within a pipe 32 until the fiber reaches the surface of a quenching bath 34.
Water is circulated through the quenching bath 34 in an overflow manner, i.e., a continuous flow of water 36 is supplied to the quenching bath 34, and the excess fluid overflows and is removed, e.g., at 38. The fiber 28 is then directed out of the -quenching bath 34 and is wound on a take-up wheel 40 which is ~ W094/07594 2 1:4 3 8 6 3 PCT/US93/09639 immersed in a second, rinsing bath 42. Again, a continuous flow of water 44 is supplied to the rinsing bath 42, and the excess fluid overflows the bath and is removed, e.g., at 46.
The hollow fiber 28 thus produced may then be removed from the take-up wheel 40 and further processed. An example of further processing includes cutting the fibers 28 to a uniform length, bundling them and drying them in any conventional manner.
A detail of a spinneret head 102 which is a part of the dry-jet wet spinning spinneret apparatus 20 is illustrated in Figures 2 and 3. The dope solution 12 enters through a dope port 104, is directed to an annular channel 106, and flows out of an annular orifice 108 in a generally downward direction.
The diluent solution 22 enters the spinneret head 102 through a diluent port 110, is directed through an inner channel 112 and flows out through a tubular orifice 114 which is in a generally concentric orientation with respect to the annular orifice 108.
Detailed DescriDt;on of the Preferred Fmhodiment The invention is directed to an asy~metrical microporous, hollow fiber membrane that includes a polyimide polymer that is highly polar. The pore size of the membrane and the molecular weight cutoff will vary depending on the application, i.e. water filtration, ultrafiltration, hemofiltration, plasma filtration (plasmapheresis), etc.
However, we define microporous to mean membranes having a pore size ranging from about O.OOl~m to 0.5~m and more preferably from about .005~m to about 0.2 ~m. We also define ~fluxn or ~water permeability~ to mean a measure of the volume of water W094/07594 2 1 ~ 3 8 6 3 PCT/US93/09639 passed by the hollow fiber membrane under pressure for a given time and area. ~Rewetting" and similar words such as rewettable, rewettability, etc., as used herein, is a description of the ability of a membrane to maintain a particular level of flux or water permeability after either cycles of wetting and drying the membrane or after steam or chemical sterilization. ~Asymmetric~ means that the pore size of the fiber varies from smaller to larger from the inner barrier layer to the outer sponge-like layer, respectively.
"Uniformly porousN and usponge-liken means that the porosity o~
the hollow fiber membrane is homogeneous throughout. In addition, Usolvents with respect to the polymer~ are typically aprotic solvents while ~non-solvents with respect to the polymerN are typically protic solvents. NAnti-solventN is a nonsolvent with respect to the polymer and is used herein when referring to additional nonsolvents that are added to the polymeric solution. ~Nonsolvents,N on the other hand, are also nonsolvents with respect to the polymer, but is used herein when referring to nonsolvents added to the precipitating solution.
The membrane is particularly well suited for medical applications where the membrane will come into contact with blood because it is biocompatible, does not activate complement, and has the remarkable ability to exhibit high sieving coefficients for middle molecules such as ~2 microglobulins and myoglobins. When used as a membrane for dialysis applications, the membrane has a pore size ranging from substantially about O.OOl~m to substantially about O.Ol~m with the average pore size 3~3 ~~ being from substantially about 0.003~m to substantially about 0.005~m.
Also surprisingly, the membrane is equally suited in all filtration applications for its unique ability to completely remove existing endotoxin from the solution being filtered.
When this unique membrane is used as a water filter, the pore size preferably ranges from about 0.005~m to about 0.5~m with an average pore size of from about 0.05~m to about O.l~m. When used as a plasma filtration membrane the maximum pore size ranges from substantially about O.l~m to substantially about 0.2~m.
The highly polar polymer in accordance with the present invention is preferably an aromatic polyimide that when precipitated as a membrane is immediately wettable without the use of polymer additives or surfactants. The preferred polyimide in accordance with the present invention is disclosed in U.S. Pat. No. 3,708,458 to Alberino. The polyimide is prepared from benzophenone-3,3',4,4'-tetracarboxylic acid dianhydride and a mixture of 4,4'-methylenebis(phenyl isocyanate) and toluene diisocyanate (2,4- or 2,6-isomer) of mixtures thereof. The polyimide includes the recurring group:

O O ~
Il 11 11 / ~ C ~ C/ - R -Il 11 O O

..~
. ~

W094/07594 ~ 1 4 3 8 6 3 PCT/US93/09639 wherein 10% to 90% of the R groups are ~ CH

and the remaining R groups include either ~ or The aromatic iso- and diisocyanates may be substituted by their amine analogs. The CAS Registry No. of the preferred polyimide is 58698-66-1. The polyimide is available from Lenzing Corp.(Austria) under the P-84 and/or HP P-84 (high purity) marks. In an alternative embodiment, a polymer based on the phenyl-indane diamine; 5(6)-amino-1-(4~-aminophenyl)-1,3-trimethylindane with a CAS Registry No. of 62929-02-6 may be used. The alternative embodiment polymer is available from Ciba-Geigy Corporation (Hawthorne, N.Y.) under the ~Matrimid 5218~ mark.

~ W094/07594 2 1 1 3 8 ~ 3 PCT/US93/09639 The structure of the polymer repeating unit is believed to consist of:

Me Me ~ ' '[~

O O

The alternative preferred embodiment may be prepared by the methods disclosed in U.S. Pat. No. 3,856,752.
The polyimide polymers useful in accordance with the present invention preferably have a molecular weight of about 30,000 to 125,000 daltons. More preferably, the molecular weight is about 35,000 to 115,000 daltons and most preferably, the molecular weight is about 40,000 to 105,000 daltons.
As stated previously, no additional additives, such as polyvinylpyrrolidone, polyethylene glycol, glycerine, cellulose or starch derivatives or amphoteric, zwitterionic, nonionic, anionic, or cationic surfactants, are needed to produce a hollow fiber membrane that wets immediately upon contact with blood, water and other aqueous solutions and maintains the rewettability for at least 6-7 sterilizations by steam or chemicals. Because no additional polymers are needed to make the resultant fiber wettable, the choice of solvents for use as the precipitating solution is critical in influencing the ~1438'63 _ hydrophilicity, structure and porosity of the fiber. In addition, the elimination of additives in the polymeric dope solution decreases and virtually eliminates all but trace amounts of solids and/or oxidizable material that is leachable from the resultant fiber. Further, the structural integrity of the resultant hollow fiber membrane is more stable after the removal of the solvent and/or antisolvents and nonsolvents.
Initially, the polyimide polymer is dissolved in a solvent. Preferably, this solvent is also miscible with water.
A representative, non-limiting list of solvents useful in the invention includes dimethylformamide (DMF), dimethylsulfoxide ~DMSO), dimethylacetamide (DMA), n-methylpyrrolidone, and mixtures thereof. Preferably, the solvent is DMF, an aprotic solvent. Depending on the desired properties of the hollow fiber, a small amount of an antisolvent may be added in small quantities to the primary solvent that is used. The addition of an antisolvent in the polymer forming solution will enhance the desired precipitate characteristics of the polymer during fiber formation. For example, adding acetic acid in the amount of 4-7 wt.% ensures that the fiber has a uniform sponge-like structure, free of voids, large vacuous spaces extending from the inner membrane wall to the outer membrane wall that can permit the passage of large molecular weight molecules if the void pierces the inner and/or outer membrane wall.
Alternatively, additional amounts of solids may be added to the polymer solution up to 25.0 wt.% to solve this problem. The homogeneous, sponge-like structure may also be achieved in accordance with the process and formulations described herein.

~1~3863 Figure 4 depicts a cross section of a hollow fiber membrane in accordance with the present invention magnified 130X
taken on a Hitachi S-800 scanning electron microscope. Figure 4B which is a lOX magnification (1300X) of the area enclosed by box 4B in Figure 4A and illustrates the ~uniform sponge-like structure~ 200 of hollow fiber membranes in accordance with the present invention. Figure 5 is a lO,OOOX view taken at a 45~
angle of cross-section of hollow fibers in accordance with the present invention showing the outer membrane wall 210 and the sponge-like inner composition 215. ~Voidsn 220, which characterize many hollow fiber membranes, may be seen by referring to Figures 6A (130X) and 6B (1300X). The absence of voids in the formed hollow fiber membrane results in a mechanically stronger fiber with enhanced diffusion rates.
Preferably, about 15-25 wt-%, more preferably, about 16-20 wt-%, and most preferably, about 17-19 wt-% of the fiber forming polyimide polymer is dissolved in the dimethylformamide solvent. When less than 15 wt-% of the polyimide polymer is used, the fibers formed may not be strong enough to withstand the stresses involved in the high speed process in accordance with the method of the present invention. In addition, test data regarding sieving and clearance characteristics are not reproducible because the fibers lack the desirable uniform sponge-like structure. Further, the fibers lack integrity due to the weakness from the voids in the fiber walls.
Higher polyimide solids may be employed in organic solvent systems if spinneret housings, feed lines, and polymer solution tanks are heated. Upon heating, the viscosity of the W094/07~94 ~ 1 4 3 8 6 3 PCT/US93/09639 polymer solution is lowered, allowing otherwise unusable polymer solution formulations to be spun. Depending upon the composition of the precipitating solution the skilled practitioner chooses, heating and/or cooling the system may influence the morphology and performance characteristics of the resultant fiber membrane.
The polymeric solution has a viscosity of about 1500-5000 cps, preferably about 2000-4000 cps, and most preferably about 3500-3800 cps at 25~C, as measured on a Brookfield (LV) viscometer. The solution is preferably filtered to remove any entrained particles (cont~min~nts or undissolved components) to prevent apparatus blockage.
The polymeric solution is spun from the outer, annular orifice of a tube-in orifice spinneret. A precipitating solution is delivered to the tube of the spinneret. The precipitating solution includes a solvent with respect to the ~ polymer and a non-solvent with respect to the polymer or a variety of non-solvents. The composition of the precipitating solution is critical because it affects the porosity, degree of uniform sponge-like structure, clearance, tensile strength, wall thickness, inner and outer diameters and flux properties of the fiber.
For example, as the weight percent of the solvent with respect to the polymer increases, fiber formation is impaired and is characterized by a ~glassyn weaker structure and it becomes increasingly difficult to Upull~ the fiber. Conversely, as the weight percent of the solvent with respect to the polymer decreases and the weight percent of water and/or other non-W094t07594 2 1 4 3 8 6 3 PCT/US93/09639 solvents with respect to the polymer increases, voids are seenin the fiber structure which may allow high molecular weight molecules to pass through the fiber if they pierce the outer membrane wall. This may best be seen in Figure 7 which S illustrates a fiber cross-section magnified 130X with voids 221 that resulted from using a precipitating solution with an increased weight percent of non-solvent with respect to the polymer. In addition, as the weight percent of water and/or other non-solvents with respect to the polymer increases, a low pore density on the outer fiber wall and a tighter closed inner wall with a low flux is seen. It will therefore be appreciated by those skilled in the art that the selection of the composition of the precipitating solution is crucial.
The composition of the precipitating solution effective to produce a hollow fiber membrane for use in hemodialysis, as well as, water filters, autologous blood filters, and plasma filters is illustrated below in Table I.

W094/07594 ~ 1 ~ 3 8 6 3 PCT/US93/09639 T~hle I

More Most Preferred Preferred Preferr Solvent with respect to polymer 50-99 wt.% 60-95 wt.% 75-90 wt.%

Water 35-1 wt.% 30-5 wt.% 20-10 wt.%

Add~l Non-Solvents with respect to polymer 15-0 wt.% 10-0 wt.% 5-0 wt.%
The table above is merely offered to guide the practitioner in formulating precipitating solution solutions.
Indeed, the practitioner may decide that it is advantageous to operate in a ~Preferred~ range for one component while operating in a nMost Preferredn range for another. In addition, depending on which formulation of precipitating solution the practitioner selects, he or she may also vary the percent solids in the polymer solution to obtain a fiber of the desired characteristics.
The water which may be used in the precipitating solution may be tap water, deionized water or water which is a product of reverse osmosis. Preferably the water has first been treated by reverse osmosis.
As stated previously, the solvent (with respect to the polymer) used in the precipitating solution is dimethylformamide (DMF), dimethylsulfoxide (DMSO), dimethylacetamide (DMA), n-methylpyrrolidone and mixtures thereof. Preferably, the solvent ~1438B3 W094/07594 ' PCT/US93/09639 is the same as that used in the polymeric fiber forming solution. More p-eferably, the solvent is DMA or DMF. Most preferably, the solvent is DMF.
Additional combinations of solvents and non-solvents, which may or may not contain salts, may be used so long as they are miscible with dimethylformamide, dimethylsulfoxide, dimethylacetamide, n-methylpyrrolidone and mixtures thereof. A
representative, non-limiting list of non-solvents (with respect to the polymer) that may be used in the precipitating solution are acetic acid, isopropanol, water, glycerol, acetic anhydride, and ethanol.
The proportions of the water, and other non-solvents (e.g. alcohol) which may make up the precipitating solution influence the morphology, clearance, permeability, and selectivity characteristics of the hollow fiber membrane. In particular, the total absence of a solvent with respect to the polymer in the precipitating solution may result in a small number of pores in the fiber wall as well as lower flux.
Further, water is clearly an important ingredient in the precipitating solution used in this membrane formation process.
Because the addition of water affects the performance characteristics of the resultant fiber membrane it is generally preferred that the proportion of water in the precipitating solution be about 1-35 wt.%, to ensure proper fiber performance characteristics. Less than about 10 wt.% of water may result in the polymeric solution precipitating too slowly forming a fiber with increased pore size. This is desirable to form a fiber for use in water filters but would not, for example, form a fiber 3~G3' ~ _ W094/07594 ' PCT/US93/09639 suitable for use as a dialyzer fiber. Conversely, a concentration of water greater than about 35 wt.% results in a fiber with lower pore density on the outside and a tighter closed inner wall with a general decrease in flux. However, when the proportion of water falls within 1-35 wt.%, we see enhanced uniformity in the desirable sponge-like structure and the hollow fiber membrane is characterized by the complete absence of voids. This uniformity results in more overall uniform flux with respect to all types of filters and tighter controls with respect to molecular cutoffs in dialyzer applications.
Initially, the highly polar polymer is diluted in DMF.
Depending on the desired properties and characteristics of the hollow fiber, a small amount of a non-solvent (with respect to the polymer) (also called anti-solvents) other than water may be added instead of using pure DMF solvent. This may enhance the precipitation of the polymer in the fiber formation. For example, the addition of 4-7 wt.% glacial acetic acid to the polymer/DMF solution enhances the uniform sponge-like structure of the resultant fiber and the fiber is further characterized by the complete absence of voids.
The polymeric dope solution is pumped, filtered and directed to the outer, ring orifice of a tube-in-orifice spinneret. At the same time, the precipitating solution is pumped to the inner coaxial tube of the spinneret. These two solutions are then delivered from the spinneret in a manner such that the polymer dope forms an annular sheath surround a flow of precipitating solution within the annulus. Preferably, the spinneret head is maintained at a temperature of about 5-85~C, more preferably,~about 15-25~C, and most preferably, about 22~C. The polymeric dope is subjected to a pressure of about 0-1400 kPa, more preferably, about 140-1000 kPa, and most preferably, about 350-850 kPa. In a preferred embodiment, the polymer dope is spun through a ring orifice having an outside diameter of about 0.018 to 0.040 inches (about 460 to 1,016 microns) and an inside diameter of about 0.008 to 0.010 inches (about 200 to 280 microns).
At the same time, precipitating solution is pumped through the tube of the spinneret at a pressure of about 0-1000 kPa, preferably about 0-100 kPa, and most preferably, about 1-20 kPa. In a preferred embodiment, the precipitating solution or diluent solution is delivered through a tube having an outside diameter of substantially about 0.010 inches (about 254 microns) and an inside diameter of substantially about .004 to .005 inches (about 100 to 127 microns).
In a preferred embodiment, in order to produce a hollow fiber having an approximately 380 micron outside diameter and an approximately 280 micron inside diameter, the polymer dope is delivered to the spinneret at a rate of substantially about 1.0-10 mL/min, more preferably, about 2-5 mL/min, most preferably, about 3-~.5 mL/min, and the precipitating solution is delivered at a rate of at least about 1.0-10 mL/min, more preferably, about 2-5 mL/min, and most preferably, about 2-3 mL/min. The spinneret is oriented in a manner such that fiber production is driven by fluid flow and by removal from the spinneret by gravity effects. Preferably, the fiber emerges W094/07594 ~ ~ ~ 3 ~ 63 PCT/US93/09639 from the spinneret and is pulled by gravity and the take-up speed in a nearly vertical direction downwards.
In order to provide satisfactory fibers in the practice of the invention, l~mi n~r fluid flow should be maintained both within the spinneret head for the polymeric solution and the precipitating solution which interact to precipitate the formed fiber. If turbulent flow is present in the spinneret head, especially within the channels which convey the polymeric dope, gas pockets may develop and ultimately form large voids in the spun fiber. Turbulent flow within the spun fluids may also result in voids within the fiber.
It is helpful to visualize the spinneret dimensions by resort to ratios of the annular orifice for passage of the polymeric dope and the coaxial tubular orifice for passage of the diluent or precipitating solution. One helpful ratio is the ratio of the cross-sectional area of the annular orifice to tubular orifice. Preferably, the ratio is greater than about 1:1, more preferably, the ratio is about 3:1 to 25:1, and most preferably, the ratio of the annular orifice to tubular orifice cross-sectional area is about 4:1 to 15:1.
Another helpful dimensional ratio is the annular ring thickness to tube inside diameter. Preferably, the ratio is greater than about 1:1, more preferably, the ratio is about 1.5:1 to 7:1, and most preferably, the ratio of the annular ring thickness to tube inside diameter is about 2:1 to 6:1.
A third helpful dimensional ratio is the outside diameter of the annular orifice to tube inside diameter.
Preferably, this ratio is greater than about 2:1, more 214~8~3 preferably, the ratio is about 3:1 to 10:1, and most preferably, the ratio of the ~nnular outside diameter to tube inside diameter is about 4:1 to 8:1.
As the fiber emerges from the spinneret, it drops in a substantially downward vertical direction over a distance of about 0.1 to lOm, more preferably, about 0.5 to 2.0 m, and most preferably, about 0.5 to 1.5m. This allows the precipitating solution to substantially precipitate the polymer in the annular dope solution forming the solid fiber capillary before it is immersed in a quenching solution. Between the spinneret and the quenching bath, the fiber drops through the atmosphere, air, air with a particular relative humidity, an augmented atmosphere, e.g., a mixture of air or air with a particular relative humidity and a gas, an inert gas, or a mixture thereof.
Preferably, for ease in processing and to produce a high quality fiber, the fiber drops through air maintained at a temperature of 0~C to 100~C, more preferably, the air is maintained at a temperature of 5~C to 50~C and most preferably at 15~C to 25~C.
Preferably the air is also maintained at a relative humidity of substantially about 10% to 99%, more preferably from substantially about 20% to 80% and most preferably from substantially about 40% to 65%. This gaseous atmosphere may be relatively stagnant, or there can be fluid flow. Preferably, the flow rate is sufficient to allow complete air change over in the spinning environment once every 30 minutes. In one preferred embodiment, the gas flow is about 10 L/min. In an alternative embodiment, the fiber may be dropped directly into the quenching bath.

21~3~63 ~_ The fiber is submerged in a tank comprising water and 0-10 wt.% other mcterials. Again, the water may be tap, deionized water, or the product of a reverse osmosis process.
The temperature of the quenching bath is preferably between about 0 to lOO'C, more preferably, about 15'C to 45 C, and most preferably, about 35'C. The water temperature directly affects the performance of the fiber. Lower temperatures can reduce the flux of the resulting fiber. Increasing the quenching bath temperature can increase the flux of the fiber.
The fiber is preferably immersed in the quenching bath for a period of about 0.1 to 10 seconds, preferably about 0.1 to 5 seconds, and most preferably, about 1 second. This residence time permits the full precipitation of the polyimide polymer to form the microporous hollow fiber.
After the quenching bath, the fiber may be further rinsed to remove any remaining solvents. This rinsing may be accomplished in a water bath arrangement. Preferably, the additional rinse is achieved in a water bath having a water temperature of about O'C-lOO C, more preferably, about 15-C-45 C, and most preferably, about 35 C. The fiber is then wound on a take-up reel. The take-up reel is preferably rotating at a speed such that the fiber is being wound at about 90-150~ of the rate at which it is being formed at the spinneret or, in other words, at approximately about 150-230 ft/min (about 45-70 m/min) More preferably, the fiber is being wound at a rate substantially equal to that at which it is being produced. In other words, the fiber is taken up with enough speed (i) to create a fiber of the desired size and (ii) to apply sufficient ~ 21~863 tension to the fiber such that it will remain taut in the take-up guide unaffect~d by ambient air currents, i.e. there is no udraft . "
The hollow fibers may then be dried by any method appropriate to general manufacturing procedures including but not limited to air, heat, vacuum, or any combination thereof.
The hollow fibers may be further processed to form useful articles including hemodialyzer cartridges, hemofilters, blood filters, water filters, etc., having improved performance levels.
For example, at a 300 mL/min flow rate, a clearance rate of at least about 225 mL/min is possible for urea; at least about 200 mL/min for creatinine; and at least about 125 mL/min for Vitamin Bl2. The flux rate possible with the fibers of the present invention is preferably greater than 500 mL/hr/mmHg/m2, more preferably is between 500-1000 mL/hr/mmHg/m2, and most preferably is greater than 1000 mL/hr/mmHg/m-. The sieving coefficient for BSA is preferably less than about 0.01, and most preferably is about 0Ø Sieving coefficients for myoglobulin were between about 0.65 and 1Ø Typical clearance rate data for fibers formed in accordance with the present invention are as follows:
Flow Rate Urea Creatinine PhosphateB-12 Cyto C

200 mL/m 175-200 165-200 155-195110-130 125-185 300 mL/m 225-290 200-270 170-250125-150 140-265 400 mL/m 250-320 215-305 195-280125-160 150-255 WO 94/07594 ~ 1 4 3 8 6 3 PCI/US93/09639 ExamDles The followinc specific examples which contain the best mode, can be used to further illustrate the invention. These examples are merely illustrative of the invention and do not 5 limit its scope.
F.x~ le A polymeric dope solution was formed by dissolving 17.5 wt.% of P-84 in dimethylformamide. The material was filtered and then pumped to a tube-in-orifice- spinneret at a rate of 4.50 mL/min and at a temperature of 24~C.
Simultaneously, a precipitating solution consisting of 80 wt.~6 dimethylformamide and 20 wt.% reverse osmosis deionized water was mixed, filtered and delivered to the spinneret at a temperature of 24~C and a rate of 2.75 mL/min.
The polymeric dope solution was delivered through the outer, annular orifice of the spinneret, which orifice had an ~ outside dimension of about 0.022 to 0.025 inches (about 560 I,lm) and an inside dimension of about 0.010 inches (about 254 ,Um).
The precipitating solution was delivered through a tube orifice 20 within the annular orifice, which tube orifice had an inside diameter of about 0.005 inches (about 127 ,um). The spinneret head was maintained at 24~C. The spinneret discharged the polymeric solution and precipitating solution downward into ambient atmosphere for a distance of about 1.5 meters into a 25 quenching bath maintained at 32~C. Formed fiber material was wound on a take-up reel at a rate of 70 m/min. The fiber was then removed from the take-up wheel, cut, bundled, soaked in a water bath at 32~C for 10 hours, dried and tested.

W094/07594 ~ PCT/~'S93/09639 Test Data #1 Fiber membranes prepared by the method recited in Example 1 had sieving coefficients of 0.0 for albumin, .82 for myoglobin and 1.0 for inulin. These fibers had the surprising advantage of having high sieving coefficients for middle molecules (molecular weights of from about 5,000 daltons to 25,000 daltons) such as ~2 microglobulins and myoglobins.
Flow Rate Urea Creatinine Phosphate B-12 Cyto C

200 mL/m 179.4 164.9 156.5 125.1 129.9 300 mL/m 225.0 198.5 182.6 140.2 143.0 400 mL/m 244.8 212.5 208.7 149.3 146.8 ~xam~le 22 The method for preparing fiber as in Example 1 was repeated using a precipitating solution of 81 wt.% DMF and 19 wt.% deionized water.
Test Data ~2 Resultant fiber membranes had sieving coefficients of 0.0 for albumin, 0.79 for myoglobin, and 1.0 for inulin.

Flow Rate Urea Creatinine Phosphate B-12 Cyto C

200 mL/m 188.1 178.3 166.7 119.8 156.9 300 mL/m 249.6 223.4 212.5 136.6 178.7 400 mL/m 281.5 246.7 233.5 139.6 184.0 Exam~le 3 The method employed in Example 1 was repeated using 17.0 wt.% of the P-84 polyimide polymer and 83 wt.% DMF. The precipitating solution comprised 81 wt.~ DMF and 19.0 wt.~

~1~38~3 W094/07594 PCT/~'S93tO9639 deionized water. Sieving coefficients were similar to the Test Data obtained for Examples 1 and 2 above for albumin and inulin with a sieving coefficient of 0.77 for myoglobulin.
Test Data #3 5 Blood Fl. Urea Creatinine Phosphate B12 Cytochrome C

200 mL/m 190.7 178.4 166.7 124.8 162.9 300 mL/m 255.2 232.45 228.0 141.5 185.7 400 mL/m 287.3 256.9 240.0 145.3 188.8 Example 4 Fibers for use in a water filter were manufactured in the following manner. A polymeric dope solution was formed by dissolving 19.0 wt.% of Matrimid 5218 in 81.0 wt.% DMF. The material was filtered and then pumped to a tube-in-orifice spinneret at a rate of 2.9 mL/min at a temperature of 23~C.

Simultaneously, a precipitating solution consisting of 85.5 wt.%
DMF and 14.5 wt.% water was mixed, filtered and delivered to the spinneret at a temperature of 23~C and a rate of 3.0 mL/min.
The polymeric dope solution was delivered through the outer, annular orifice of the spinneret having an outside diameter of 940 ~m and an inside diameter of 254 ~m. The precipitating solution was delivered through a tube orifice within the annular orifice having an inside diameter of about 127 ~m. The spinneret head was maintained at about 23~C. The spinneret discharged the column of polymeric solution and precipitating solution downward for a distance of about 0.81 m into a quenching water bath maintained at a temperature of 35~C.
The fiber was wound on a take-up reel at a rate of about '~ W094/07594 ~ 1 4 3 8 6 3 ~ PCT/US93/09639 45m/min. Cut bundles were soaked in a 46~C water bath for 16 hours. Eiber bundles were dried and tested. sased on a 0.05 m~
test mat, at 5 psi, water permeability was calculated to be 500 mL/hr/mmHg/m2 .
Fxample 5 Fibers for use in a plasma filter were manufactured in the following manner. The method for preparing fiber as in Example 25 was repeated using a polymeric dope solution consisting of 16.75% P-84 polymer and 83.25 wt.% DMF. The precipitating solution included 85.5 wt.% DMF and 14.5 wt.%
deionized water. Eibers had a sieving coefficient of 0.65 using a 0.1% solution of fluorescein isothiocyanate dextran (Sigma), a molecular weight marker of approximately 500,000 Daltons. Water permeability was in excess of 900 mL/hr/mmHg/m2.
Example 6 Fibers for use in a water filter were manufactured in the following manner. A polymeric dope solution was formed by dissolving 16.75 wt.% P-84 polymer in 83.25 wt.% DMF. The material was filtered and then pumped to a tube-in -orifice spinneret at a rate of 4.5 mL/min at a temperature of 23~C.
Simultaneously, a precipitating solution consisting of 85.5 wt.%
DMF and 14.5 wt.% water was mixed, filtered and delivered to the spinneret at a temperature of 23~C and a rate of 3.0 mL/min.
Fibers were further processed in accordance with the method of Example 4. A water filter (1.5 m2 of fiber) containing the fibers manufactured using the above formulation was tested for water permeability. At 8.6 psi, filters had a water permeability of 1020 mL/hr/mmHg/m~. At 10.0 psi, filters had a water perme~bility of 1320 mL/hr/mmHg/m2.
ExamDle 7 Fibers for use in water filters were prepared in the following manner. A polymeric dope solution was formed by dissolving 15.2 wt.% P-84 polyimide polymer in 79.80 wt.% DMF
and 5.0 wt.% glacial acetic acid. The material was filtered and pumped to a tube-in-orifice spinneret at a rate of 4.1 mL/min.
A precipitating solution comprised of 50 wt.% DMF and 50 wt.%
glacial acetic acid was mixed, filtered and delivered to the spinneret at a rate of 4.5 mL/min.
The polymeric dope solution was delivered through the outer, annular orifice of the spinneret having an outside dimension of about 0.029 inches (737 ~m) and an inside dimension of about 0.01 inches (about 254 ~m). The precipitating solution was delivered through a tube orifice within the annular orifice having an inside diameter of about 0.005 inches (about 127 ~m).
Precipitated fiber was quenched in a reverse osmosis water bath and taken up at a rate of 49 m/min.
Water Permeability All fibers produced in the Examples 1-7 above were evaluated for water permeability (flux) in the following manner.
Water was passed through the lumens of potted test fibers with the filtering unit in a horizontal position. The ultrafiltrate port on the inlet side of the unit was plugged. Pressure monitors were placed at all inlet and outlet ports. With flow through the unit, backpressure was applied to the fiber outlet side of the unit to increase ultrafiltrate flow across the ~143863 W094/07594 ~ PCT/US93/09639 fibers. Three data points were taken at 10~, 50%, and 80-100%
ultrafiltrate flow and transmembrane pressure (TMP) was calculated. Ultrafiltrate flow was plotted against TMP and the - slope of this curve was used to determine flux or water permeability. As noted above, all of the above fibers for use as water filters, hemofilters and dialyzers had water permeabilities in excess of 500 mL/hr/mmHg/m2.
Endotoxin Tests Filtering units prepared substantially in accordance with Examples 1-7 were tested with two liters of a bicarbonate solution containing a 15EU/ml endotoxin challenge at high flow rates. No endotoxin was passed even after repeated recirculations.
The endotoxin solution was prepared by adding 0.25 ml of endotoxin (Control standard endotoxin, lot #47, 25 mcg/ml endotoxin, available from Associates of Cape Cod, MA) to a bicarbonate solution. The bicarbonate solution was made from an in-house preparation of bicarbonate concentrate powder by mixing the powder with sufficient reverse osmosis water to make 2 1/2 gallons. The limulus amebocyte lysate used for the assay had a sensitivity of 0.06 EU/ml.
The bicarbonate solution tested negative for endotoxin. The solution with the added endotoxin tested positive at the ninth two-fold dilution tube (256X) giving an endotoxin concentration between 15.4 and 30.7.
Test solution was recirculated from a two liter flask.
The test solution was pumped through the filtering unit by a Sarns portable pump code 5M6002 serial #3397.

W094/07594 2 1 ~ 3 8 6 3 PCT/US93/09639 Test Data #4 Endotoxin testing~
Time Endotoxin Levels Observed After Filterin~ Before Filterinq 1 minute none (<0.06 EUml) 15.4 5 minutes none 0.96 EU/ml 30 minutes none none 60 minutes none none Test Data #5 Endotoxin testing:
Endotoxin Levels Observed After Filterinq Before Filterinq 151 minute none (<0.06 EU/ml) 5 minutes none 0.49 EU/ml 30 minutes none none 60 minutes none none 120 minutes none none Although the description of the preferred embodiment and best mode has been presented, it is contemplated that various changes, including those mentioned above, could be made without deviating from the spirit of the present invention. It is therefore desired that the present embodiment be considered in all respects as illustrative, not restrictive, and that reference be made to the appended claims rather than to the foregoing description to indicate the scope of the invention.

Claims (24)

CLAIMS:
1. An asymmetric, microporous, hollow fiber membrane comprising a polyimide polymer wherein said polyimide polymer has a molecular weight of about 30,000 daltons to about 125,000 daltons and wherein said hollow fiber membrane has an inner diameter of approximately 280 microns and an outer diameter of approximately 380 micron and a pore size range of approximately .001 microns to about .5 microns.
2. The hollow fiber membrane of Claim 1 wherein said polyimide polymer comprises a polymer having the structure:

wherein 10% to 90% of the R groups are and the remaining R groups are or
3. The hollow fiber membrane of Claim 1 wherein said polyimide polymer comprises a polymer having the structure:

4. The hollow fiber membrane of Claim 1 wherein said membrane has a water permeability of at least 500 mL/hr/mmHg/m2.
5 . An asymmetric, microporous, hollow fiber membrane comprising a polyimide polymer having the structure:

wherein 10% to 90% of the R groups are and the remaining R groups are or wherein at a blood flow rate of 200mL/min, said hollow fiber membrane has a high clearance rate of 175-190 mL/min for urea, 150-180 mL/min for creatinine and phosphorous, about 88-125.1 mL/min for Vitamin B12 and about 125-165 mL/min for Cytochrome C for fibers having 1.25 m2 active surface area; and high sieving coefficients of less than 0.01 for albumin, from about .65 to 1.0 for myoglobin and 1.0 for inulin.
6 . The hollow fiber membrane of Claims 1 or 5 wherein said fiber can withstand take-up rates in excess of 40 m/min.
7. The hollow fiber membrane of Claim 1 wherein said membrane rewets by maintaining a flux of at least 500 mL/hr/mmHg/m2 for about six sterilizations and wherein said fiber is further characterized by having 0.0% wetting agent additives selected from the group of hydrophilic polymers, nonionic, anionic, or amphoteric surfactants.
8. A process for the manufacture of an asymmetric, microporous hollow fiber membrane comprising the steps of:
(a) passing, through an outer annular orifice of a tube-in-orifice spinneret, a polymeric solution comprising about 15-25 wt.% of a highly polar polyimide polymer dissolved in a solvent with respect to the polymer, said solution having a viscosity of about 1500-5000 cps, to form an annular liquid, wherein the tube-in-orifice spinneret has an inner tube, said inner tube and said outer annular orifice each having a cross-sectional area such that the ratio of the respective cross-sectional areas of the outer annular orifice to the inner tube is about 3:1 to 25:1;

(b) simultaneously passing in laminar fluid flow, through the inner tube of the spinneret, into the center of the annular liquid, a precipitating solution comprising about (i) 99-65 wt.% of a solvent with respect to the polymer, and (ii) 1-35 wt.% of a non-solvent with respect to the polymer, wherein the precipitating solution interacts with the polymeric solution to form an annular polymer precipitate;
(c) passing the annular polymer precipitate through a vertical drop of from 0.5 to 2.0 meters in an atmosphere or an augmented atmosphere comprising air, air with a relative humidity of from 10% to about 99%, an inert gas and mixtures thereof;
(d) quenching the annular polymer precipitate in a bath maintained at about 15-45°C to form a hollow fiber; and (e) taking up the hollow fiber at a rate of about 40-70 meters/min.
9. The process of Claim 8 wherein said organic solvent is selected from the group consisting of dimethylformamide, dimethyylsulfoxide, dimethylacetamide, n-methylpyrrolidone and mixtures thereof.
10. The process of Claim 8 wherein said solvent with respect to the polymer comprises dimethylformamide.
11. The process of Claim 9 wherein said solvent comprises dimethylformamide.
12. The process of Claim 9 wherein said precipitating solution comprises:
(i) 75-90 wt.% of a solvent with respect to the polymer;
(ii) 20-10 wt.% water; and (iii) 5-0 wt.% additional non-solvent with respect to the polymer.
13. The process of Claim 12 wherein said solvent comprises dimethylformamide.
14. The process of Claim 12 wherein said non-solvent comprises isopropanol.
15. The process of Claim 8 wherein said polyimide polymer comprises a polymer having the structure:

wherein 10% to 90% of the R groups are and the remaining R groups are or
16. The process of Claim 8 wherein said polyimide polymer comprises a polymer having the structure:

17. The process of Claim 8 wherein said precipitating solution comprises about 81 wt.% dimethylformamide and 19 wt.% water.
18. The process of Claim 8 wherein said precipitating solution comprises about 85 wt.% dimethylformamide and 15 wt.% water.
19. The process of Claim 8 wherein said precipitating solution comprises about 85.5 wt.% dimethylformamide and 14.5 wt.% water.
20. The process of Claim 8 wherein said precipitating solution comprises 50 wt.% dimethylformamide and 50 wt.% water.
21. The process of Claim 8 wherein said polymeric solution comprises about 15 wt.% of a polyimide polymer, about 80 wt.% dimethylformamide, and 5.0 wt.% glacial acetic acid.
22 . A process for the manufacture of an asymmetric, microporous hollow fiber membrane comprising the steps of:
(a) passing, through an outer annular orifice of a tube-in-orifice spinneret, a polymeric solution comprising about 16-18 wt.% of a highly polar polyimide polymer dissolved in a solvent with respect to said polymer, said solution having a viscosity of about 1500-5000 cps, to form an annular liquid;

(b) simultaneously passing in laminar fluid flow, through the inner tube of the spinneret, into the center of the annular liquid, a precipitating solution comprising:
(i) about 80 wt.% of a solvent with respect to said polymer, and (ii) about 20 wt.% water, wherein the precipitating solution interacts with the polymeric solution to form an annular polymer precipitate;
(c) passing the annular polymer precipitate through a vertical drop of from 0.5 to about 2.0 meters in an atmosphere or an augmented atmosphere comprising air, air with a relative humidity of from 10% to about 99%, an inert gas and mixtures thereof;
(d) quenching the annular polymer precipitate in a bath maintained at about 15-45°C to form a hollow fiber; and (e) taking up the fiber at a rate of about 40-70 meters/min;
wherein said hollow fiber membrane is uniformly porous, absent of voids, and has a water permeability of at least 500 mL/hr/mmHg/m2.
23. The process of Claim 22 wherein said polyimide polymer comprises a polymer having the structure:
wherein 10% to 90% of the R groups are and the remaining R groups are or
24. The process of Claim 22 wherein said polyimide polymer comprises a polymer having the structure:

CA002143863A 1992-10-07 1993-10-07 Hollow fiber membrane incorporating a polyimide and process for preparing same Expired - Fee Related CA2143863C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95802792A 1992-10-07 1992-10-07
US07/958,027 1992-10-07
US08/058,904 US5762798A (en) 1991-04-12 1993-05-06 Hollow fiber membranes and method of manufacture
US08/058,904 1993-05-06
PCT/US1993/009639 WO1994007594A2 (en) 1992-10-07 1993-10-07 Hollow fiber membrane incorporating a polyimide and process for preparing same

Publications (2)

Publication Number Publication Date
CA2143863A1 CA2143863A1 (en) 1994-04-14
CA2143863C true CA2143863C (en) 1999-06-08

Family

ID=26738152

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002143863A Expired - Fee Related CA2143863C (en) 1992-10-07 1993-10-07 Hollow fiber membrane incorporating a polyimide and process for preparing same

Country Status (12)

Country Link
US (2) US5762798A (en)
EP (1) EP0663853A1 (en)
JP (1) JP2887527B2 (en)
KR (1) KR950703400A (en)
AU (2) AU668268B2 (en)
CA (1) CA2143863C (en)
FI (1) FI951646A (en)
HU (1) HUT70894A (en)
NO (1) NO951343L (en)
PL (1) PL173977B1 (en)
RU (1) RU95110700A (en)
WO (1) WO1994007594A2 (en)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100346590B1 (en) * 1994-06-07 2002-09-18 미쯔비시 레이온 가부시끼가이샤 Porous Polysulfone Membrane and Process for Producing the Same
US5635067A (en) * 1995-03-14 1997-06-03 Praxair Technology, Inc. Fluid separation membranes prepared from blends of polyimide polymers
US6355730B1 (en) * 1995-06-30 2002-03-12 Toray Industries, Inc. Permselective membranes and methods for their production
US6171496B1 (en) * 1995-12-15 2001-01-09 Microban Products Company Antimicrobial filter cartridge
JP3804097B2 (en) * 1996-03-29 2006-08-02 東レ株式会社 Support stockings with excellent wearing comfort
ATE327034T1 (en) * 1996-12-25 2006-06-15 Asahi Kasei Medical Co Ltd METHOD FOR PRODUCING A HOLLOW FIBER MEMBRANE, HOLLOW FIBER MEMBRANE AND HOLLOW FIBER DIALYZER
DE69822912T2 (en) * 1997-01-30 2004-10-28 ITT Manufacturing Enterprises, Inc., Wilmington Method of making a membrane
WO1998052683A1 (en) 1997-05-19 1998-11-26 Asahi Medical Co., Ltd. Polysulfone-base hollow-fiber hemocathartic membrane and processes for the production thereof
US7144505B2 (en) * 1997-09-18 2006-12-05 Baxter International Inc. Melt-spun polysulfone semipermeable membranes and methods for making the same
US6478960B1 (en) * 1997-12-17 2002-11-12 Asahi Medical Co., Ltd. Manufacturing method of artificial organ, hollow fiber, and dialyzer of hollow fiber membrane type
KR100289413B1 (en) * 1997-12-30 2001-05-02 구광시 Polysulfone hollow fiber membrane and manufacturing method thereof
US6510949B1 (en) * 1998-04-09 2003-01-28 Papcel - Papier Und Cellulose, Technologie, Und Handels-Gmbh Filter material having adjustable wettability and method for its manufacture
US6138579A (en) * 1998-04-21 2000-10-31 National Steel Car Limited Autorack railcar adjustable decking structure and method
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US6180008B1 (en) * 1998-07-30 2001-01-30 W. R. Grace & Co.-Conn. Polyimide membranes for hyperfiltration recovery of aromatic solvents
GB9824621D0 (en) * 1998-11-11 1999-01-06 Univ Strathclyde Super selective hollow fibre membranes
CA2359050C (en) * 1999-01-21 2007-05-29 Membrana Gmbh Integrally asymmetrical polyolefin membrane
JP4582751B2 (en) * 1999-06-16 2010-11-17 テイジン・アラミド・ビー.ブイ. Method for producing fibers
US6261457B1 (en) 1999-11-12 2001-07-17 Minntech Corporation Method and product for cleaning hollow fiber material and filter
JP4211168B2 (en) * 1999-12-21 2009-01-21 東レ株式会社 Dialyzer manufacturing method and sterilization method
US6736972B1 (en) 2000-03-24 2004-05-18 Immunocept, L.L.C. Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US6802820B1 (en) * 2000-04-13 2004-10-12 Transvivo, Inc. Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
US6994811B2 (en) * 2001-05-22 2006-02-07 Millipore Corporation Method of manufacturing membranes and the resulting membranes
US6551039B1 (en) * 2000-09-11 2003-04-22 National Steel Car Limited Auto rack rail road car with reduced slack
FR2817769B1 (en) * 2000-12-08 2003-09-12 Hospal Ind APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD OR PLASMA COMPRISING A WET SEMI-PERMEABLE MEMBRANE AND METHODS OF MANUFACTURE
US20020139719A1 (en) * 2000-12-28 2002-10-03 Minhas Bhupender S. Removal of thiophenic sulfur from gasoline by membrane separation process
EP1359995A4 (en) * 2001-01-23 2004-04-07 Innovasep Technology Corp Asymmetric hollow fiber membranes
DK1399193T3 (en) 2001-02-16 2014-03-31 Piedmont Renal Clinics P A Automated peritoneal dialysis system and method of in-line sterilization of the dialysate
ATE415194T1 (en) * 2001-04-18 2008-12-15 Asahi Kasei Kuraray Medical Co ASYMMETRIC POROUS FILMS AND METHOD FOR PRODUCING THE SAME
CN1263534C (en) * 2001-07-24 2006-07-12 旭化成医疗株式会社 Hollow fiber membrane for purifying blood and method for preparation thereof
WO2003014394A1 (en) * 2001-08-03 2003-02-20 Asahi Medical Co., Ltd. Method of evaluating biocompatibility
US20040247682A1 (en) * 2001-10-04 2004-12-09 Hiroyuki Sugaya Hydrophilic material and process for producing the same
US6890435B2 (en) * 2002-01-28 2005-05-10 Koch Membrane Systems Hollow fiber microfiltration membranes and a method of making these membranes
US6942633B2 (en) * 2002-03-22 2005-09-13 Twin Star Medical, Inc. System for treating tissue swelling
SE522692C2 (en) * 2002-03-27 2004-03-02 Gambro Lundia Ab Method and apparatus for removing partially protein bound substances
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) * 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
CA2495459C (en) * 2002-08-13 2009-10-27 Arbios Technologies Inc. Selective plasma exchange therapy
EP1547628B1 (en) * 2002-09-12 2011-06-08 Asahi Kasei Kuraray Medical Co., Ltd. Plasma purification membrane and plasma purification system
US7025804B2 (en) * 2002-12-02 2006-04-11 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Method for separating hydrocarbon-containing gas mixtures using hydrocarbon-resistant membranes
US7250545B2 (en) * 2003-01-27 2007-07-31 L'air Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude At L'exploration Des Procedes Georges Claude Method of separating olefins from mixtures with paraffins
SE0203855L (en) * 2002-12-20 2004-06-21 Gambro Lundia Ab Perm-selective membrane
SE0203857L (en) 2002-12-20 2004-06-21 Gambro Lundia Ab Perm-selective membrane and process for its manufacture
US20040118779A1 (en) * 2002-12-23 2004-06-24 Rawson James Rulon Young Unitary water filter assembly for removal of chemical and microbiological contaminants
US6929532B1 (en) * 2003-05-08 2005-08-16 Lsi Logic Corporation Method and apparatus for filtering a chemical polishing slurry of a wafer fabrication process
DE602004025577D1 (en) * 2003-06-02 2010-04-01 Ge Osmonics Inc UNGENE AND METHOD FOR THE PRODUCTION THEREOF
CN100515550C (en) * 2003-06-02 2009-07-22 Ge奥斯莫尼克斯公司 Materials and methods for processing non-aqueous mixtures
CA2435538A1 (en) * 2003-07-18 2005-01-18 Universite Laval Solvent resistant asymmetric integrally skinned membranes
TWI406703B (en) * 2003-11-17 2013-09-01 Asahi Kasei Medical Co Ltd Purify blood with hollow fiber membrane and use its blood purifier
US20050147757A1 (en) * 2004-01-07 2005-07-07 Roh Il J. Method for wetting hydrophobic porous polymeric membranes to improve water flux without alcohol treatment
DE102004008221B4 (en) * 2004-02-19 2006-01-26 Membrana Gmbh Dialysis membrane with improved agent molecule removal
DE102004008220B4 (en) * 2004-02-19 2006-01-12 Membrana Gmbh High-flux dialysis membrane with improved separation behavior
US7354392B2 (en) 2004-02-25 2008-04-08 Transvivo Inc. Structurally optimized hollow fiber membranes
JP3642065B1 (en) * 2004-03-22 2005-04-27 東洋紡績株式会社 Permselective separation membrane and method for producing a selectively permeable separation membrane
JP3636199B1 (en) * 2004-03-23 2005-04-06 東洋紡績株式会社 Polysulfone-based permselective hollow fiber membrane bundle, method for producing the same and blood purifier
US7393383B2 (en) * 2005-01-14 2008-07-01 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Separation membrane made from blends of polyimide with polyamide or polyimide-amide polymers
EP1848474B1 (en) 2005-02-07 2013-06-12 Hanuman LLC Platelet rich plasma concentrate apparatus and method
US7866485B2 (en) * 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006087859A1 (en) * 2005-02-17 2006-08-24 Toray Industries, Inc. Aromatic polyamide porous film, process for producing the same and secondary battery
US8101009B2 (en) 2005-03-02 2012-01-24 L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Separation membrane by controlled annealing of polyimide polymers
US7422623B2 (en) 2005-03-02 2008-09-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Separation membrane by controlled annealing of polyimide polymers
CN1899678B (en) * 2005-07-19 2010-04-28 天津工业大学 Method for producing hollow fiber film
US20070036929A1 (en) * 2005-08-09 2007-02-15 The Boeing Company Thin film applique
CA2635534C (en) 2005-12-30 2014-07-29 Neurotech Usa Inc. Micronized device for the delivery of biologically active molecules and methods of use thereof
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
PT2074248E (en) * 2006-10-17 2011-05-12 Dsm Ip Assets Bv Cut resistant yarn and products containing the yarn
JP5113178B2 (en) * 2006-10-18 2013-01-09 ガンブロ・ルンディア・エービー Hollow fiber membrane and method for producing hollow fiber membrane
US20080135481A1 (en) * 2006-12-06 2008-06-12 General Electric Company Polyarylethernitrile hollow fiber membranes
US7977451B2 (en) * 2006-12-15 2011-07-12 General Electric Company Polyarylether membranes
US7681741B2 (en) * 2006-12-15 2010-03-23 General Electric Company Functional polyarylethers
US20110168631A1 (en) * 2006-12-15 2011-07-14 General Electric Company Methods and apparatuses for water filtration using polyarylether membranes
US7695628B2 (en) * 2006-12-15 2010-04-13 General Electric Company Polyarylether membranes
US7669720B2 (en) * 2006-12-15 2010-03-02 General Electric Company Functional polyarylethers
CN101680126B (en) * 2007-03-23 2013-09-18 索维高级聚合物股份有限公司 Coal combustion flue gas filters
US7806276B2 (en) * 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US20080302713A1 (en) * 2007-06-05 2008-12-11 Gilbert Patrick Antimicrobial filter cartridge
SG154369A1 (en) * 2008-02-05 2009-08-28 Inst Of Environmental Science Method for the production of an asymmetric hollow fiber membrane
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
WO2009142434A2 (en) * 2008-05-19 2009-11-26 한양대학교 산학협력단 Hollow fiber, dope solution composition for forming a hollow fiber, and method for manufacturing a hollow fiber using the same
WO2009152212A1 (en) 2008-06-10 2009-12-17 Aquatech International Corporation Preparation of high performance ultra filtration hollow fiber membrane
US7985339B2 (en) * 2008-08-25 2011-07-26 General Electric Company Polyarylether compositions bearing zwitterion functionalities
WO2010065484A1 (en) * 2008-12-04 2010-06-10 The University Of Akron Polymer composition and dialysis membrane formed from the polymer composition
US8187475B2 (en) * 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
MY150232A (en) * 2009-04-08 2013-12-31 Universiti Malaysia Pahang Fabrication of asymmetric polysulfone membrane for drinking water purification (bio- membrane)
US20100272780A1 (en) * 2009-04-23 2010-10-28 Vincent Ling CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOF
CA2716502C (en) * 2009-05-15 2015-06-16 Interface Biologics, Inc. Antithrombogenic hollow fiber membranes and filters
GB0909967D0 (en) * 2009-06-10 2009-07-22 Membrane Extraction Tech Ltd Polyimide membrane
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8545701B2 (en) 2009-08-18 2013-10-01 Maher Isaac Kelada Induced symbiotic osmosis [ISO] for salinity power generation
CA2776748A1 (en) * 2009-10-08 2011-04-14 Neurotech Usa, Inc. Use of pedf in an encapsulated cell-based delivery system
EP2542712B1 (en) * 2010-03-05 2023-09-13 NX Filtration Holding B.V. Process for manufacturing a hollow fibre membrane
NL1038359C2 (en) * 2010-03-31 2012-06-27 Aquamarijn Res B V Device and method for separation of circulating tumor cells.
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
AU2011277176B2 (en) 2010-07-16 2014-08-21 X-Flow Bv Grafted poly(arylsulfone) and a process for grafting a poly(arylsulfone)
JP2014506119A (en) 2010-12-02 2014-03-13 ニューロテック ユーエスエー, インコーポレイテッド Cell lines secreting anti-angiogenic antibody scaffolds and soluble receptors and uses thereof
CN103501878B (en) 2011-02-04 2020-06-09 弗雷塞尼斯医疗保健控股公司 Performance enhancing additives for fiber formation and polysulfone fibers
US8614288B2 (en) * 2011-06-17 2013-12-24 Uop Llc Polyimide gas separation membranes
JP6062945B2 (en) * 2011-09-06 2017-01-18 エスアールアイ インターナショナルSRI International Process for making PBI hollow fiber asymmetric membranes for gas and liquid separation
US9321015B2 (en) * 2011-09-06 2016-04-26 Sri International Process for fabricating PBI hollow fiber asymmetric membranes for gas separation and liquid separation
EP2604331B1 (en) * 2011-12-15 2017-01-25 Gambro Lundia AB Doped membranes
CN104284711B (en) * 2012-03-14 2016-07-06 三菱丽阳株式会社 The manufacture method manufacturing device and hollow form multiple aperture plasma membrane of hollow form multiple aperture plasma membrane
EP2857087A4 (en) * 2012-05-24 2016-02-17 Lg Chemical Ltd Reverse osmosis membrane
EP2854884A1 (en) 2012-05-30 2015-04-08 Neurotech USA, Inc. Cryopreserved implantable cell culture devices and uses thereof
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
RU2510435C1 (en) * 2012-12-06 2014-03-27 Закрытое акционерное общество "Институт новых углеродных материалов и технологий" (ЗАО "ИНУМиТ") Method of producing polyamide imide-based hollow fibre based and hollow fibre
US8974668B2 (en) 2013-02-15 2015-03-10 Maher Isaac Kelada Hollow fiber membrane element and methods of making same
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
WO2014194228A1 (en) * 2013-05-31 2014-12-04 The Johns Hopkins University Application of carbon nanotubes or carbon particles onto hollow fiber polymeric materials
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US10456356B2 (en) 2015-05-27 2019-10-29 Neurotech Usa, Inc. Use of encapsulated cell therapy for treatment of ophthalmic disorders
MY177960A (en) 2015-06-25 2020-09-28 Uop Llc Chemically and uv cross-linked high selectivity polyimide membranes for gas separations
WO2017069282A1 (en) * 2015-10-23 2017-04-27 国立大学法人東京医科歯科大学 Drug delivery device
RU2614024C1 (en) * 2016-02-10 2017-03-22 Публичное акционерное общество криогенного машиностроения (ПАО "Криогенмаш") Composition for moulding hollow fibre membrane
CN105908347A (en) * 2016-03-16 2016-08-31 浙江宝娜斯袜业有限公司 Space gold socks
US10633631B1 (en) 2017-03-01 2020-04-28 Gerald R. Harris Platelet rich plasma preparation system and devices
EP3813990A1 (en) 2018-06-27 2021-05-05 BL Technologies, Inc. Alkali-stable nanofiltration composite membrane and method of manufacture thereof
KR20230003549A (en) 2020-04-27 2023-01-06 크레이튼 폴리머스 엘엘씨 dehumidification system
JP2023528283A (en) 2020-05-31 2023-07-04 クレイトン・ポリマーズ・エル・エル・シー air cooling system
CN112316746B (en) * 2020-09-09 2023-01-13 万华化学集团股份有限公司 Ultrahigh molecular weight polyethylene hollow fiber membrane with bimodal pore size distribution and preparation method thereof

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623827A (en) * 1961-10-20
US3423491A (en) * 1964-09-02 1969-01-21 Dow Chemical Co Permselective hollow fibers and method of making
US3526588A (en) * 1967-09-21 1970-09-01 Amicon Corp Macromolecular fractionation process
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
FR2105502A5 (en) * 1970-09-09 1972-04-28 Rhone Poulenc Sa
US3691068A (en) * 1971-01-08 1972-09-12 Amicon Corp Dialysis membrane and its use
US3708458A (en) * 1971-03-16 1973-01-02 Upjohn Co Copolyimides of benzophenone tetracarboxylic acid dianhydride and mixture of diisocyanates
FR2138334B1 (en) * 1971-05-24 1974-03-08 Rhone Poulenc Sa
US3763055A (en) * 1971-07-07 1973-10-02 Us Interior Microporous support for reverse osmosis membranes
US3775308A (en) * 1972-05-18 1973-11-27 Interior Method for preparation of composite semipermeable membrane
US3948823A (en) * 1972-08-01 1976-04-06 Allied Chemical Corporation Method of making permselective interpolymer membranes
US4051300A (en) * 1973-09-03 1977-09-27 Gulf South Research Institute Hollow synthetic fibers
US4113628A (en) * 1974-06-05 1978-09-12 E. I. Du Pont De Nemours And Company Asymmetric polyimide membranes
JPS568645B2 (en) * 1974-09-05 1981-02-25
JPS51119069A (en) * 1975-03-20 1976-10-19 Nippon Oil Co Ltd Method of producing permeable film
IT1040274B (en) * 1975-07-30 1979-12-20 Consiglio Nazionale Ricerche PROCEDURE FOR PREPARATION OF ANISOTROPIC MEMBRANES SUPPORTED FOR REVERSE OSMOSIS BASED ON SYNTHETIC POLYAMIDES
US4020230A (en) * 1975-10-03 1977-04-26 The Dow Chemical Company Microporous polyethylene hollow fibers and process of preparing them
FR2331602A1 (en) * 1975-11-14 1977-06-10 Rhone Poulenc Ind COMPOSITIONS BASED ON POLYMERS OF THE POLYSULFONE TYPE FOR REVERSE OSMOSIS MEMBRANES
US4203847A (en) * 1977-05-25 1980-05-20 Millipore Corporation Making porous membranes and the membrane products
JPS5812932B2 (en) * 1977-06-30 1983-03-10 日本ゼオン株式会社 Hollow fiber manufacturing method
JPS5416378A (en) * 1977-07-08 1979-02-06 Asahi Chem Ind Co Ltd Polysulfone semipermeable membrane
DE2751910B2 (en) * 1977-11-21 1979-09-20 Hoechst Ag, 6000 Frankfurt Permselective, asymmetric hemofiltration membrane with heteroporous structure
JPS54145379A (en) * 1978-05-02 1979-11-13 Asahi Chem Ind Co Ltd Aromatic polysulfone hollow fiber semipermeable membrane
EP0023406B1 (en) * 1979-07-26 1983-04-13 Ube Industries, Ltd. Process for preparing aromatic polyimide semipermeable membranes
CA1151020A (en) * 1980-05-01 1983-08-02 Richard W. Baker Reverse osmosis composite fiber membrane
DE3018667C2 (en) * 1980-05-16 1994-06-16 Bend Res Inc Fiber membrane for reverse osmosis
FR2482468A1 (en) * 1980-05-19 1981-11-20 Bend Res Inc Reverse osmosis composite membrane is hollow fibre - whose inner surface is coated with interfacial salt rejecting membrane
US4444663A (en) * 1980-09-16 1984-04-24 Terumo Corporation Membrane and method for manufacture thereof
US4432875A (en) * 1981-05-29 1984-02-21 Brunswick Corporation Semi-permeable membranes and processes for making the same
JPS57205517A (en) * 1981-06-11 1982-12-16 Ube Ind Ltd Preparation of polyimide hollow fiber
JPS5895541A (en) * 1981-11-30 1983-06-07 Mitsubishi Chem Ind Ltd Gas separating membrane
DE3149976A1 (en) * 1981-12-17 1983-06-30 Hoechst Ag, 6230 Frankfurt MACROPOROUS ASYMMETRIC HYDROPHILE MEMBRANE MADE OF SYNTHETIC POLYMER
US4655840A (en) * 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
SE8204103L (en) * 1982-07-02 1984-01-03 Gambro Lundia Ab FILTRATION MEMBRANE AND SET TO MAKE THE MEMBRANE
US4532041A (en) * 1983-05-13 1985-07-30 Exxon Research And Engineering Co. Asymmetric polyimide reverse osmosis membrane, method for preparation of same and use thereof for organic liquid separations
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
EP0162446B2 (en) * 1984-05-21 1991-07-24 Mitsubishi Rayon Co., Ltd. Hollow-fiber filter module
ATE68991T1 (en) * 1984-06-13 1991-11-15 Inst Nat Rech Chimique PROCESSES FOR THE PRODUCTION OF HOLLOW FIBERS AND THEIR USE IN MEMBRANE SEPARATION PROCESSES.
US4906375A (en) * 1984-07-14 1990-03-06 Fresenius, Ag Asymmetrical microporous hollow fiber for hemodialysis
US4933083A (en) * 1985-04-15 1990-06-12 Hoechst Celanese Corp. Polybenzimidazole thin film composite membranes
US4900502A (en) * 1985-08-29 1990-02-13 Bend Research, Inc. Hollow fiber annealing
NL8602402A (en) * 1986-09-23 1988-04-18 X Flow Bv METHOD FOR MANUFACTURING HYDROFILE MEMBRANES AND SIMILAR MEMBRANES
US4746474A (en) * 1986-10-10 1988-05-24 Hoechst Celanese Corporation Ultrathin polyimide polymers films and their preparation
GB8628938D0 (en) * 1986-12-03 1987-01-07 Domnick Hunter Filters Ltd Microporous polyetherimide membranes
US4900449A (en) * 1987-05-20 1990-02-13 Gelman Sciences Filtration membranes and method of making the same
US4964990A (en) * 1987-05-20 1990-10-23 Gelman Sciences, Inc. Filtration membranes and method of making the same
DE3720665A1 (en) * 1987-06-23 1989-01-05 Schael Wilfried DEVICE FOR HAEMODIALYSIS AND HAEMOFILTRATION
US4826599A (en) * 1987-07-10 1989-05-02 Union Carbide Corporation Composite membranes and their manufacture and use
DE3734880C1 (en) * 1987-10-15 1989-03-23 Fresenius Ag Device for hemodialysis with protection system against incorrect composition of the dialysis fluid
NL8702924A (en) * 1987-12-04 1989-07-03 Akzo Nv Asymmetric hollow fibre gas sepn., membranes - made by extruding polymer soln. through annular die into non-solvent for polymer etc.
JPH0263531A (en) * 1988-05-30 1990-03-02 Terumo Corp Production of hollow fiber membrane
CA1337621C (en) * 1988-08-23 1995-11-21 Kazuyuki Yamasaki Membrane filter material having excellent organic solvent resistance, method for formation of membrane filter and process for preparation of bismaleimide polymer to be used formembrane filter
US5049276A (en) * 1988-10-13 1991-09-17 Fuji Photo Film Co., Ltd. Hollow fiber membrane
US4963303A (en) * 1989-02-16 1990-10-16 Exxon Research & Engineering Company Ultrafiltration polyimide membrane and its use for recovery of dewaxing aid
NL8901090A (en) * 1989-04-28 1990-11-16 X Flow Bv METHOD FOR MANUFACTURING A MICROPOROUS MEMBRANE AND SUCH MEMBRANE
US5015270A (en) * 1989-10-10 1991-05-14 E. I. Du Pont De Nemours And Company Phenylindane-containing polyimide gas separation membranes
US4983191A (en) * 1989-10-10 1991-01-08 E. I. Du Pont De Nemours And Company Production of aromatic polyimide membranes
JPH07121343B2 (en) * 1990-03-15 1995-12-25 宇部興産株式会社 Gas separation hollow fiber membrane and method for producing the same
US5067970A (en) * 1990-05-11 1991-11-26 W. R. Grace & Co.-Conn. Asymmetric polyimide membranes
DE4037818A1 (en) * 1990-11-28 1992-06-04 Akzo Gmbh CAPILLARY MEMBRANE FOR GAS SEPARATION
US5085676A (en) * 1990-12-04 1992-02-04 E. I. Du Pont De Nemours And Company Novel multicomponent fluid separation membranes
US5151227A (en) * 1991-03-18 1992-09-29 W. R. Grace & Co.-Conn. Process for continuous spinning of hollow-fiber membranes using a solvent mixture as a precipitation medium
US5181940A (en) * 1991-08-01 1993-01-26 Union Carbide Industrial Gases Technology Corporation Hollow fiber membranes
US5163977A (en) * 1991-08-22 1992-11-17 The Dow Chemical Company Semi-permeable gas separation membranes containing non-ionic surfactants possessing improved resistance to thermal compaction and processes for making and using the same
US5480554A (en) * 1992-05-13 1996-01-02 Pall Corporation Integrity-testable wet-dry-reversible ultrafiltration membranes and method for testing same

Also Published As

Publication number Publication date
HUT70894A (en) 1995-11-28
KR950703400A (en) 1995-09-20
AU676448B2 (en) 1997-03-06
CA2143863A1 (en) 1994-04-14
US5762798A (en) 1998-06-09
PL173977B1 (en) 1998-05-29
US5683584A (en) 1997-11-04
JP2887527B2 (en) 1999-04-26
FI951646A0 (en) 1995-04-06
RU95110700A (en) 1997-01-10
AU4447396A (en) 1996-05-23
NO951343D0 (en) 1995-04-06
WO1994007594A2 (en) 1994-04-14
NO951343L (en) 1995-04-07
AU668268B2 (en) 1996-04-26
FI951646A (en) 1995-04-06
HU9500740D0 (en) 1995-04-28
PL308302A1 (en) 1995-07-24
AU5584294A (en) 1994-04-26
EP0663853A1 (en) 1995-07-26
JPH07507494A (en) 1995-08-24
WO1994007594A3 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
CA2143863C (en) Hollow fiber membrane incorporating a polyimide and process for preparing same
EP0568045B1 (en) Polysulfone-based hollow fiber membrane and process for manufacturing the same
US4772391A (en) Composite membrane for reverse osmosis
US9776143B2 (en) Low cut-off ultrafiltration membranes
EP2567750B1 (en) Hollow fiber membrane
EP2845641B1 (en) Permselective asymmetric membranes with high molecular weight polyvinylpyrrolidone, the preparation and use thereof
EP0819024A1 (en) Dialysate filter
EP3248672A1 (en) Porous hollow fiber filtration membrane
CA2136006C (en) Hollow fiber membrane incorporating a surfactant and process for preparing same
EP0579749B2 (en) Fiber spinning process and product thereof
CN213556376U (en) Composite hollow fiber filter membrane and filter
EP0636403A2 (en) Cellulose acetate hemodialysis membrane
EP0824960A1 (en) Hollow-fiber membrane of polysulfone polymer and process for the production thereof
WO2016182015A1 (en) Porous hollow fiber membrane and manufacturing method therefor
JP2000225326A (en) Method for cleaning selective permeable membrane
US5693694A (en) Low and medium flux membranes
JP3422657B2 (en) Hollow fiber membrane for dehumidification

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed